
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Tarsons Products Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
Key metrics and details at a glance.

Price Band
₹662
Per Share
Lot Size
22 Shares

Minimum Investment
₹14,564

Issue Size
₹988.2 Cr

Face Value
₹2
Per Share
IPO Type
Book Building

Retail Quota
35%

QIB Quota
50%

NII Quota
15%
Important dates for your applying strategy.
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
50.75%
Promoter Holding (Post-Issue)
51%
Issue Type
Book Building
ISIN
INE144Z01023
Tarsons Products Limited is an Indian labware company engaged in designing, development, manufacturing and marketing of `consumables', `reusables' and `others' including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies CROs, diagnostic companies and hospitals. (Source: Frost and Sullivan Report). It is also engaged in the manufacturing of a range of quality labware products which helps scientific discovery and improve healthcare. It currently operates through our five manufacturing facilities located in West Bengal. It caters to a diverse range of end customers across various sectors which include research organizations, academic institutions, pharmaceutical companies, CROs, academic institutions, diagnostic companies and hospitals. It distributes its products to these end customers on a pan-India basis through authorised distributors. It supplies products to life sciences industry under its brand label "TARSONS WITH THE WORDS -TRUST DELIVEREDTM".
Revenue, profit after tax and total assets across the last 3 reported financial years.
Amount in ₹ crore
How the company plans to utilize IPO proceeds.
The funds raised through this IPO will be used for:
Initial public offer of 15,465,861 equity shares of face value of Rs. 2 each ("Equity Shares") of Tarsons Products Limited (The "Company" or the "Issuer") for cash at a price of Rs. 662 per equity share (including a share premium of Rs. 660 per equity share) ("Offer Price") aggregating to Rs. 1023.47* crores (The "Offer") comprising a fresh issue of 2,265,861* equity shares aggregating to Rs. 149.634* crores by the company (The "Fresh Issue") and an offer for sale of 13,200,000 equity shares aggregating to Rs. 873.84* crores comprising of 390,000* equity shares by Sanjive Sehgal aggregating to Rs. 25.81* crores, 310,000* equity shares by Rohan Sehgal aggregating to Rs. 20.52* crores (Sanjive Sehgal and Rohan Sehgal aggregating to Rs. 46.34* crores, together "Promoter Selling Shareholders") and 12,500,000* equity shares aggregating to Rs. 827.50# crores by Clear Vision Investment Holdings Pte. Limited (The "Investor Selling Shareholder", together with the promoter selling shareholders, the "Selling Shareholders" and such equity shares, the "Offered Shares") (The "Offer for Sale"). The offer includes a reservation of 60,000* equity shares, aggregating to Rs. 3.60* crores (constituting 0.11% of the post-offer paid-up equity share capital), for subscription by eligible employees (The "Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as "Net Offer". The offer and net offer shall constitute 29.07% and 28.95% (subject to finalization of basis of allotment), respectively, of the post-offer paid-up equity share capital of the company. The face value of equity shares is Rs. 2 each. The offer price is 331 times the face value of the equity shares. *The company and the selling shareholders in consultation with the brlms, have offered a discount of 9.21% of the offer price (equivalent of Rs. 61 per equity share) to eligible employees bidding in the employee reservation portion. * Subject to finalization of basis of allotment Bids cans be made for a minimum of 22 equity and in multiple of 22 shares thereafter.
*Subject to approvals and market conditions.
Key competitive advantages and factors to consider before investing.
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
According to the Frost & Sullivan Report, we cater to the global laboratory equipment (glassware and plasticware) market which is expected to register a growth of 4.90% CAGR from 2020 to 2025 to reach USD 20.5 billion by 2025 from USD 16.2 billion in 2020. With an increasing penetration expected in the coming years, plastic labware is expected to replace glassware products by another 15.00% to reach a market share of approximately 67.00% by Fiscal 2025, given plastic products are superior in terms of shelf life, handling, and safety benefits. As a result, the global plastic laboratory products market which was estimated to be USD 8.4 billion in Fiscal 2020 and is expected to expand at a CAGR of approximately 10.50% to reach approximately USD 13.8 billion by Fiscal 2025. The plastic labware market in India is estimated as Rs. 12,250 million as of Fiscal 2020 in value terms and estimated to expand at a CAGR of 16.00% to reach approximately Rs. 25,755 million by Fiscal 2025. According to the Frost & Sullivan Report, with increased investments by the Government of India in pharmaceuticals and biotech R&D, the research ecosystem in India presents a significant opportunity for labware market in the near future, which in turn will open multiple avenues for export of labware products from India.
Tarsons Products Limited was incorporated as `Tarsons Products Private Limited' on July 5, 1983, at Kolkata, West Bengal, India as a private limited company under the Companies Act, 1956. The Company was subsequently converted into a public limited company pursuant to a special resolution passed by its Shareholders at the extraordinary general meeting held on May 10, 2021, and the name of the Company was changed to `Tarsons Products Limited'. A fresh certificate of incorporation consequent upon conversion to a public limited company was issued on June 14, 2021
Amount in ₹ crore
Amount in ₹ crore
Figures in ₹ crore, on a consolidated basis, as reported for FY24 to FY26.